Private Trust Company’s abrdn Life Sciences Investors HQL Stock Holding History

Private Trust Company’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.7K	Buy	+1,000	New	+$20.2K	﹤0.01%	1829

Other funds holding HQL

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Formidable Asset Management Cincinnati, Ohio $680M AUM 8.59% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return

Advisors Asset Management Monument, Colorado $6.34B AUM 22.84% 1-Year Est. Return

Blue Bell Private Wealth Management Blue Bell, Pennsylvania $840M AUM 13.7% 1-Year Est. Return

UHLMANN PRICE SECURITIES Skokie, Illinois $1.86B AUM 66.72% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return

Z3 Capital Partners Richmond, Virginia $482M AUM 40.01% 1-Year Est. Return

Private Trust Company's HQL Position: Q3 2026 in Review

Private Trust Company opened a new position in abrdn Life Sciences Investors (HQL) in Q3 2026: 1,000 shares worth $18.7K. The stake represents ﹤0.01% of the portfolio and ranks #1829 among its holdings.

51 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

Private Trust Company held 1,000 shares of abrdn Life Sciences Investors worth $18.7K as of Q3 2026.
abrdn Life Sciences Investors was a new Private Trust Company position in Q3 2026.
abrdn Life Sciences Investors made up ﹤0.01% of Private Trust Company's portfolio in Q3 2026, its #1829 holding.
51 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Private Trust Company's 13F filing for Q3 2026, filed 20 Oct 2026.